Back to Search
Start Over
Spinal Muscular Atrophy Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and MOA, ROA by DelveInsight | Genentech Inc, Chugai Pharma, Cytokinetics Inc., Ionis Pharma, Genzyme Corp
- Source :
- M2 Presswire. December 20, 2024
- Publication Year :
- 2024
-
Abstract
- M2 PRESSWIRE-December 20, 2024-: Spinal Muscular Atrophy Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and MOA, ROA by DelveInsight | Genentech Inc, Chugai Pharma, Cytokinetics Inc., Ionis Pharma, Genzyme Corp [...]
- Subjects :
- Cytokinetics Inc. -- Product development
Genentech Inc. -- Product development
Biological products industry -- Product development
Medical research -- Health aspects
Medicine, Experimental -- Health aspects
Clinical trials -- Health aspects
Spinal muscular atrophy -- Health aspects
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.820651582